AAP
THC icon

Arax Advisory Partners’s Tenet Healthcare THC Stock Holding History

Arax Advisory Partners’s Portfolio THC Stock Details THC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.97M Buy
10,515
+9,189
+693% +$1.69M 0.01% 864
2026
Q1 		$252K Buy
1,326
+985
+289% +$208K 0.01% 968
2025
Q4 		$67.8K Sell
341
-24,748
-99% -$5M ﹤0.01% 1471
2025
Q3 		$5.09M Buy
25,089
+24,224
+2,800% +$4.3M 0.07% 226
2025
Q2 		$152K Buy
865
+251
+41% +$37.8K 0.01% 761
2025
Q1 		$82.6K Buy
614
+507
+474% +$66.8K 0.01% 781
2024
Q4 		$13.5K Sell
107
-109
-50% -$16.2K ﹤0.01% 1371
2024
Q3 		$35.9K Buy
216
+130
+151% +$19.7K ﹤0.01% 846
2024
Q2 		$11.4K Buy
+86
New +$10.4K ﹤0.01% 1201
2017
Q3 		– Sell
-81
Closed -$2K – 496
2017
Q2 		$2K Sell
81
-1,101
-93% -$19.2K ﹤0.01% 465
2017
Q1 		$20K Hold
1,182
– – 0.01% 281
2016
Q4 		$18K Buy
+1,182
New +$21.2K 0.01% 272

Other funds holding THC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GCM
Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Arax Advisory Partners's THC Position: Q2 2026 in Review

Arax Advisory Partners increased its Tenet Healthcare (THC) stake by 693% in Q2 2026, buying an estimated $1.69M and bringing the position to 10,515 shares worth $1.97M. The position accounts for 0.01% of the portfolio, ranked #864.

Arax Advisory Partners first reported a position in THC in Q4 2016 and has held it in 12 quarters since. The position peaked at $5.09M in Q3 2025. 678 funds tracked by Wall St. Rank hold THC as of Q2 2026.

  • Arax Advisory Partners held 10,515 shares of Tenet Healthcare worth $1.97M as of Q2 2026.
  • Arax Advisory Partners bought 9,189 Tenet Healthcare shares in Q2 2026, an estimated $1.69M.
  • Tenet Healthcare made up 0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #864 holding.
  • Arax Advisory Partners first reported a position in Tenet Healthcare in Q4 2016 and has held it in 12 quarters since.
  • Arax Advisory Partners's Tenet Healthcare position peaked at $5.09M in Q3 2025.
  • 678 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.